SI

Singular Genomics Systems

3 known investors

singulargenomics.com ↗

Singular Genomics develops spatial pathology technology to map molecules and cells directly in tissue for disease characterization. The company serves researchers and pathologists in biomedical research and diagnostics.

Founders & leadership

JS

John StarkCEO

AB

Aaron BerlinCTO

Investors · 3

AR

ARCH Venture PartnersChicago · $50K – $250M

CA

Catalio Capital Management, LPNew York

F-

F-Prime Capital PartnersCambridge · $3M – $10M